TCL Archive The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six. June 23, 2000
TCL Archive Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial November 10, 1989
TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies June 22, 2012